tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Upstream Bio, Inc.’s Verekitug: A Promising Buy with Blockbuster Potential in Asthma and COPD Markets
PremiumRatingsUpstream Bio, Inc.’s Verekitug: A Promising Buy with Blockbuster Potential in Asthma and COPD Markets
2M ago
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
Premium
Market News
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
2M ago
Upstream Bio Reports Progress in Respiratory Trials
Premium
Company Announcements
Upstream Bio Reports Progress in Respiratory Trials
2M ago
Upstream Bio’s Promising Trials and Strategic Outlook Drive Buy Rating
PremiumRatingsUpstream Bio’s Promising Trials and Strategic Outlook Drive Buy Rating
2M ago
Upstream Bio’s COPD Study: A Potential Game-Changer for Investors
Premium
Company Announcements
Upstream Bio’s COPD Study: A Potential Game-Changer for Investors
3M ago
Upstream Bio’s Verekitug Study: A Potential Game-Changer for Severe Asthma Treatment
Premium
Company Announcements
Upstream Bio’s Verekitug Study: A Potential Game-Changer for Severe Asthma Treatment
3M ago
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug
PremiumRatingsPositive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug
4M ago
Upstream Bio Announces Positive Phase 2 Trial Results
Premium
Company Announcements
Upstream Bio Announces Positive Phase 2 Trial Results
4M ago
Upstream Bio’s verekitug meets endpoints in Phase 2 rhinosinusitis trial
Premium
The Fly
Upstream Bio’s verekitug meets endpoints in Phase 2 rhinosinusitis trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100